CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluatedHyori Kim, Kyung‐Nam Koh|Oncology Letters|2023Cited by 14
[CD13- and CD33-negative acute myelocytic leukemia (FAB classification; M2) with morphological changes and CD13 expression on recurrence].Yasutaka Aoyama, N Tatsumi, Hiroshi Kanashima et al.|PubMed|2001Cited by 0